Van ECK Associates Corp Boosts Stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Van ECK Associates Corp grew its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 18.4% in the fourth quarter, HoldingsChannel reports. The firm owned 1,760 shares of the biopharmaceutical company’s stock after buying an additional 273 shares during the quarter. Van ECK Associates Corp’s holdings in Ultragenyx Pharmaceutical were worth $74,000 […]
Van ECK Associates Corp grew its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 18.4% in the fourth quarter, HoldingsChannel reports. The firm owned 1,760 shares of the biopharmaceutical company’s stock after buying an additional 273 shares during the quarter. Van ECK Associates Corp’s holdings in Ultragenyx Pharmaceutical were worth $74,000 […]
